Concepedia
Statistics
Publications
26
Citations
2.7K
H-Index
21
Active since
1992
Affiliations
Pfizer (United States)(Current)
Zoetis (United States)
W.E. Upjohn Institute for Employment Research
University of Auckland
Cancer Society of New Zealand
Andrea J. Gonzales is an author at Pfizer (United States) specializing in medicine, natural sciences, and molecular biology.
Top concepts
MedicineHivImmunologyBiochemistryNatural SciencesMolecular BiologyVirologyCell BiologyDrug DiscoveryDna Replication
Publications per year
1992–2023
PF00299804, an Irreversible Pan-ERBB Inhibitor, Is Effective in Lung Cancer Models with <i>EGFR</i> and <i>ERBB2</i> Mutations that Are Resistant to Gefitinib
Jeffrey A. Engelman, Kreshnik Zejnullahu, Christopher-Michael Gale et al. · Cancer Research · 2007 · 713 citations · Full text
Oclacitinib (<scp>APOQUEL</scp><sup>®</sup>) is a novel Janus kinase inhibitor with activity against cytokines involved in allergy
Andrea J. Gonzales, Jill Bowman, Gregory J. Fici et al. · Journal of Veterinary Pharmacology and Therapeutics · 2014 · 236 citations · Full text
Antitumor activity and pharmacokinetic properties of PF-00299804, a second-generation irreversible pan-erbB receptor tyrosine kinase inhibitor
Andrea J. Gonzales, Kenneth E. Hook, Irene W. Althaus et al. · Molecular Cancer Therapeutics · 2008 · 220 citations · Full text
Steady-state kinetic studies with the non-nucleoside HIV-1 reverse transcriptase inhibitor U-87201E.
Irene W. Althaus, James J. Chou, Andrea J. Gonzales et al. · Journal of Biological Chemistry · 1993 · 164 citations · Full text
Steady-state Kinetic Studies, Biochemistry, Natural Sciences +15
The quinoline U-78036 is a potent inhibitor of HIV-1 reverse transcriptase
Irene W. Althaus, Andrea J. Gonzales, James J. Chou et al. · Journal of Biological Chemistry · 1993 · 162 citations · Full text
Viral Replication, Potent Inhibitor, Immunology +19
1–5 of 26